Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Payables (2020 - 2023)

Terns Pharmaceuticals (TERN) has disclosed Payables for 4 consecutive years, with $3.3 million as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Payables rose 58.79% year-over-year to $3.3 million, compared with a TTM value of $3.3 million through Sep 2023, up 58.79%, and an annual FY2022 reading of $1.6 million, down 22.62% over the prior year.
  • Payables was $3.3 million for Q3 2023 at Terns Pharmaceuticals, down from $5.5 million in the prior quarter.
  • Across five years, Payables topped out at $5.5 million in Q2 2023 and bottomed at $935000.0 in Q4 2020.
  • Average Payables over 4 years is $2.4 million, with a median of $1.9 million recorded in 2021.
  • The sharpest move saw Payables crashed 60.52% in 2022, then soared 469.06% in 2023.
  • Year by year, Payables stood at $935000.0 in 2020, then soared by 127.38% to $2.1 million in 2021, then decreased by 22.62% to $1.6 million in 2022, then skyrocketed by 102.13% to $3.3 million in 2023.
  • Business Quant data shows Payables for TERN at $3.3 million in Q3 2023, $5.5 million in Q2 2023, and $2.7 million in Q1 2023.